Latanoprost Medications for Glaucoma

Latanoprost Info

Clinical Overview of Latanoprost

Latanoprost belongs to the prostaglandin analog class of ophthalmic agents. It is designed to lower intra-ocular pressure by improving fluid outflow from the eye. This active compound is the key component in several eye-drop products, most notably the brand Xalatan.

The molecule is administered as a sterile solution placed on the surface of the eye. Its primary therapeutic purpose is to help manage pressure-related eye conditions, providing a pharmacological option for patients who need long-term control.

Formulations Featuring This Active Compound

In Singapore, Latanoprost is supplied primarily as single-dose or multi-dose eye-drop bottles. The formulation is an aqueous solution that may contain preservatives to maintain sterility. Both generic versions and the branded product Xalatan are available through pharmacies and hospitals. While the concentration is typically 0.005 %, the packaging and excipients can differ between manufacturers.

Eye Conditions Where It Is Commonly Used

• Open-angle glaucoma - The most frequent diagnosis where reducing eye pressure is essential.
• Ocular hypertension - Elevated pressure without clear glaucoma signs, monitored regularly by eye specialists.
• Pseudoexfoliation glaucoma - A subtype where debris accumulates and pressure rises.
• Secondary glaucoma - Cases linked to trauma or inflammation that benefit from pressure control.

Patients with these conditions often require an ongoing regimen to maintain a stable pressure level, and Latanoprost provides a convenient once-daily dosing schedule.

How It Lowers Eye Pressure

After the drops are placed in the lower eyelid pocket, the compound spreads across the eye surface. It triggers subtle changes in the eye’s drainage pathways, particularly the uveoscleral route, allowing fluid to exit more easily. This action leads to a gradual and sustained reduction in intra-ocular pressure, which can help protect the optic nerve over time.

Safety Profile and Possible Reactions

Common Responses

• Mild eye irritation or a feeling of warmth after application.
• Temporary darkening of the iris or eyelash growth, which are usually reversible if treatment stops.

Rare but Serious Signals

• Sudden eye pain, vision loss, or severe redness that does not improve.
• Allergic swelling of the eyelid or surrounding skin.

Populations Requiring Caution

• Pregnant or nursing individuals, as safety data are limited.
• People with known hypersensitivity to prostaglandin analogs or any component of the eye-drop solution.

Interaction Awareness

• Alcohol consumption does not directly affect the drops, but systemic medications that also influence eye pressure may alter overall effectiveness.
• Certain ocular drugs, such as non-steroidal anti-inflammatory eye drops, could interfere with the desired pressure-lowering effect. Detailed interaction lists are provided on the specific medication’s information page.

Practical Points for Use

Eye-drop bottles should be stored at room temperature, away from direct sunlight. The solution remains stable until the expiration date printed on the label. Typical treatment may be short-term for acute pressure spikes or long-term for chronic glaucoma management. The exact duration and any adjustments depend on the individual product, such as Xalatan, and the patient’s response.

For precise instructions on dosing, administration technique, and length of therapy, refer to the specific medication’s clinical information.

Key Terms Explained

• Intra-ocular pressure (IOP): The fluid pressure inside the eye that, when elevated, can damage the optic nerve.
• Uveoscleral outflow: One of the pathways through which aqueous humor leaves the eye, targeted by prostaglandin analogs.
• Pseudoexfoliation: A condition where flaky material builds up in the eye, increasing pressure risk.
• Hyperemia: Redness of the eye caused by increased blood flow, sometimes seen after drop use.

Important Usage Disclosure

This article provides an educational summary of Latanoprost as an active substance and does not constitute medical advice. Individual medicines containing this compound, including Xalatan, may differ in formulation, strength, and usage directions. The information here is offered without liability for clinical decisions. Patients are advised to review the labeling of their specific product and seek guidance from a healthcare professional.